$CM Falls 3.6% After CIBC Files 424B2 Pricing Supplement

CIBC’s stock ($CM) fell 3.6% on Aug 19, 2026 after the bank filed a Form 424B2 “pricing supplement” tied to its prospectus materials.

What CIBC announced

Canadian Imperial Bank of Commerce filed a Primary Offering Prospectus document: a Form 424B2. The filing is a pricing supplement dated August 17, 2026, submitted under an existing registration statement (Registration No. 333-294072). It references a stack of related documents, including a product supplement and a stock-linked underlying supplement, plus a prospectus supplement and prospectus. In plain English: this is the formal paperwork that sets out the specific terms for a structured, stock-linked offering under CIBC’s broader shelf registration.

What it means for CIBC

A 424B2 pricing supplement is typically about details — the “fine print” that turns a general prospectus framework into an actual, sellable product. Because the filing is tied to “stock-linked” underlying materials, it signals CIBC is continuing to package and distribute market-linked notes or similar structured products. That can matter because these offerings are part of how large banks meet client demand for tailored exposures and payoffs, while also managing their own hedging and funding needs. The filing itself doesn’t spell out performance or earnings, but it does show CIBC keeping its capital-markets distribution pipeline active through registered offerings.

How the stock reacted

$CM started the session at $122.25 and moved lower as the day went on.

Window	Move
5 min	-0.7%
10 min	-0.5%
30 min	-0.4%
1 hour	-1.4%
end of day	-3.6%

On a market-adjusted basis, the stock’s same-day move was -3.5% versus SPY.